Literature DB >> 2076719

Depression of drug metabolizing activity in the human liver by interferon-alpha.

H Okuno1, Y Kitao, M Takasu, H Kano, K Kunieda, T Seki, Y Shiozaki, Y Sameshima.   

Abstract

The depressant effect of interferon-alpha on drug metabolizing activity in the liver has been investigated in 12 patients with chronic active hepatitis B. 7-methoxy-coumarin (7-MC) O-demethylase and 7-ethoxycoumarin (7-EC) O-deethylase, in specimens obtained by liver biopsy, were measured before and after interferon treatment. 7-MC and 7-EC O-dealkylase activity were significantly reduced after interferon treatment, from 13.4 to 9.24 nmol.g-1 liver.min-1, and from 3.22 to 2.16 nmol.g-1 liver.min-1, respectively. The magnitude of the fall varied widely between individual patients. The study provides the first direct evidence that interferon-alpha can impair the activity of drug metabolizing enzymes in the human liver.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2076719     DOI: 10.1007/BF00315411

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  16 in total

1.  Serum 2',5'-oligoadenylate synthetase activity during interferon treatment of chronic hepatitis B.

Authors:  M Shindo; T Okuno; M Matsumoto; M Takeda; T Takino; J Sokawa; A Iwata; Y Sokawa
Journal:  Hepatology       Date:  1988 Mar-Apr       Impact factor: 17.425

2.  Depression of theophylline elimination following BCG vaccination.

Authors:  J D Gray; K W Renton; O R Hung
Journal:  Br J Clin Pharmacol       Date:  1983-12       Impact factor: 4.335

3.  Homogeneous interferon from E. coli depresses hepatic cytochrome P-450 and drug biotransformation.

Authors:  G Singh; K W Renton; N Stebbing
Journal:  Biochem Biophys Res Commun       Date:  1982-06-30       Impact factor: 3.575

4.  Relationship between the antiviral effects of interferons and their abilities to depress cytochrome P-450.

Authors:  K W Renton; G Singh; N Stebbing
Journal:  Biochem Pharmacol       Date:  1984-12-01       Impact factor: 5.858

5.  Modulation of natural killing activity by lymphoblastoid interferon in cancer patients.

Authors:  H S Koren; C P Brandt; C Y Tso; J Laszlo
Journal:  J Biol Response Mod       Date:  1983

6.  Effects of three recombinant human leukocyte interferons on drug metabolism in mice.

Authors:  A Parkinson; J Lasker; M J Kramer; M T Huang; P E Thomas; D E Ryan; L M Reik; R L Norman; W Levin; A H Conney
Journal:  Drug Metab Dispos       Date:  1982 Nov-Dec       Impact factor: 3.922

7.  Increased expression of human monocyte HLA-DR antigens and Fc gamma receptors in response to human interferon in vivo.

Authors:  J Rhodes; D H Jones; N M Bleehen
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

8.  Effects of interferon-inducing agents on hepatic cytochrome P-450 drug metabolizing systems.

Authors:  G J Mannering; K W Renton; R el Azhary; L B Deloria
Journal:  Ann N Y Acad Sci       Date:  1980       Impact factor: 5.691

9.  Altered theophylline pharmacokinetics during acute respiratory viral illness.

Authors:  K C Chang; T D Bell; B A Lauer; H Chai
Journal:  Lancet       Date:  1978-05-27       Impact factor: 79.321

10.  Depression of cytochrome P-450 and alterations of protein metabolism in mice treated with the interferon inducer polyriboinosinic acid X polyribocytidylic acid.

Authors:  N J Gooderham; G J Mannering
Journal:  Arch Biochem Biophys       Date:  1986-11-01       Impact factor: 4.013

View more
  6 in total

1.  Potentiation of warfarin by interferon.

Authors:  Y Adachi; Y Yokoyama; T Nanno; T Yamamoto
Journal:  BMJ       Date:  1995-07-29

Review 2.  Clinical pharmacokinetics of tretinoin.

Authors:  M B Regazzi; I Iacona; C Gervasutti; M Lazzarino; S Toma
Journal:  Clin Pharmacokinet       Date:  1997-05       Impact factor: 6.447

3.  Pharmacokinetics of ritonavir and delavirdine in human immunodeficiency virus-infected patients.

Authors:  Mark J Shelton; Ross G Hewitt; John Adams; Andrew Della-Coletta; Steven Cox; Gene D Morse
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

4.  Effects of acute febrile infectious diseases on the oral pharmacokinetics and effects of nitrendipine enantiomers and of bisoprolol.

Authors:  P A Soons; C Grib; D D Breimer; W Kirch
Journal:  Clin Pharmacokinet       Date:  1992-09       Impact factor: 6.447

Review 5.  Clinical toxicity of the interferons.

Authors:  T Vial; J Descotes
Journal:  Drug Saf       Date:  1994-02       Impact factor: 5.606

Review 6.  Mechanism of idiosyncratic drug induced liver injury (DILI): unresolved basic issues.

Authors:  Rolf Teschke; Jack Uetrecht
Journal:  Ann Transl Med       Date:  2021-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.